Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIA Clinical Biomarker Trial of Aspirin and Arginine Restriction in Colorectal Cancer Patients

NCT00578721 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT00578721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIA Clinical Biomarker Trial of Aspirin and Arginine Restriction in Colorectal Cancer Patients
Lead sponsor
University of California, Irvine
Phase
Phase 2
Overall status
Completed
Start date
September 24, 2008
Completion date
November 26, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer